How should I manage an extremely high blood urea nitrogen (BUN) in a patient receiving sustained low‑efficiency dialysis (SLED)?

Management of Extremely High BUN on SLED

Sustained low-efficiency dialysis (SLED) is highly effective at rapidly reducing extremely elevated BUN levels, typically achieving 80% reduction within 48 hours, and should be continued with extended treatment duration as longer SLED sessions are independently associated with improved survival. 1

Understanding BUN Reduction Kinetics on SLED

SLED demonstrates exceptional small solute clearance capabilities that make it ideal for managing severe azotemia:

• Rapid BUN reduction: Within 48 hours of continuous SLED (C-SLED), BUN decreases by approximately 80% and serum creatinine by 73% 1
• High dialysis dose delivery: SLED achieves a mean Kt/V of 1.40 per treatment with minimal urea disequilibrium (postdialytic rebound only 4.1%) 2
• Weekly clearance: SLED provides a weekly Kt/V of 8.4 ± 1.8, with equivalent renal clearance (EKR) of approximately 29 ml/min, comparable to continuous renal replacement therapy (CRRT) 3

Optimal SLED Prescription for Severe Azotemia

Target a minimum delivered Kt/V of 1.2 per session, though higher doses (Kt/V 1.4) are associated with better outcomes in critically ill patients. 4, 2

Treatment Parameters:

• Duration: 8-12 hour nocturnal treatments, 6 days per week 3, 5
• Blood flow rate: 200 ml/min 3
• Dialysate flow rate: 300-350 ml/min 2, 3
• Consider hemofiltration augmentation: Adding 1 liter/hour of saline hemofiltration enhances clearance 3

Critical Management Considerations

Extend Treatment Duration

Longer SLED duration is independently associated with lower mortality in multivariate analysis. 1 Do not prematurely discontinue SLED even after achieving substantial BUN reduction—continue until clinical stability is achieved and the underlying cause is addressed.

Nutritional Support is Essential

• Higher BUN levels associated with total parenteral nutrition (TPN) administration paradoxically correlated with lower mortality risk in patients receiving ≥48 hours of C-SLED 1
• This suggests that adequate protein/nutritional delivery is critical despite ongoing high clearance
• Do not restrict protein intake to manage elevated BUN in SLED patients 4, 6

Monitor Adequacy Using Single-Pool Kt/V

• Single-pool urea kinetic modeling adequately describes SLED due to minimal urea disequilibrium 2
• Formal variable-volume single-pool (VVSP) modeling provides accurate assessment without requiring equilibrated post-dialysis samples 2
• Phase out urea reduction ratio (URR) in favor of Kt/V for more precise dose measurement 4

Anticoagulation Strategy

SLED can be routinely performed without systemic anticoagulation using saline flushes alone. 3

• 65% of SLED treatments can be performed heparin-free 3
• Filter clotting occurs in 18% of heparin treatments versus 29% of heparin-free treatments (not statistically significant) 3
• This is particularly advantageous in critically ill patients at high bleeding risk

Prognostic Implications

Despite excellent azotemic control with SLED, the Sequential Organ Failure Assessment (SOFA) score remains the strongest predictor of mortality, along with lower mean arterial pressure and blood pH. 1 Extremely high BUN reflects severe illness burden rather than inadequate dialysis once appropriate SLED is initiated.

Key Predictors of Mortality on SLED:

• Higher SOFA score 1
• Lower mean arterial pressure 1
• Lower blood pH 1
• Shorter SLED duration 1

Common Pitfalls to Avoid

• Do not use equilibrated Kt/V (eKt/V) calculations: The additional complexity of waiting 30 minutes post-dialysis or mathematical manipulations adds no documented advantage for SLED 4
• Do not restrict dietary protein: The National Cooperative Dialysis Study demonstrated that adequate protein intake is essential to prevent increased morbidity even with elevated BUN 6
• Do not discontinue SLED prematurely: Treatment duration is independently associated with survival 1